Clathrin adaptor AP-1-mediated Golgi export of amyloid precursor protein is crucial for the production of neurotoxic amyloid fragments.
Adaptor Proteins, Vesicular Transport
Alzheimer Disease
/ genetics
Amyloid Precursor Protein Secretases
/ metabolism
Amyloid beta-Peptides
/ genetics
Amyloid beta-Protein Precursor
/ genetics
Amyloidosis
Golgi Apparatus
/ metabolism
Humans
Neurotoxicity Syndromes
Transcription Factor AP-1
/ genetics
Alzheimer’s disease
adaptor protein 1
amyloid precursor protein
endosome
protein trafficking (Golgi)
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
03
11
2021
revised:
08
06
2022
accepted:
09
06
2022
pubmed:
27
6
2022
medline:
9
9
2022
entrez:
26
6
2022
Statut:
ppublish
Résumé
One of the hallmarks of Alzheimer's disease is the accumulation of toxic amyloid-β (Aβ) peptides in extracellular plaques. The direct precursor of Aβ is the carboxyl-terminal fragment β (or C99) of the amyloid precursor protein (APP). C99 is detected at elevated levels in Alzheimer's disease brains, and its intracellular accumulation has been linked to early neurotoxicity independently of Aβ. Despite this, the causes of increased C99 levels are poorly understood. Here, we demonstrate that APP interacts with the clathrin vesicle adaptor AP-1 (adaptor protein 1), and we map the interaction sites on both proteins. Using quantitative kinetic trafficking assays, established cell lines and primary neurons, we also show that this interaction is required for the transport of APP from the trans-Golgi network to endosomes. In addition, disrupting AP-1-mediated transport of APP alters APP processing and degradation, ultimately leading to increased C99 production and Aβ release. Our results indicate that AP-1 regulates the subcellular distribution of APP, altering its processing into neurotoxic fragments.
Identifiants
pubmed: 35753347
pii: S0021-9258(22)00614-7
doi: 10.1016/j.jbc.2022.102172
pmc: PMC9352552
pii:
doi:
Substances chimiques
Adaptor Proteins, Vesicular Transport
0
Amyloid beta-Peptides
0
Amyloid beta-Protein Precursor
0
Transcription Factor AP-1
0
Amyloid Precursor Protein Secretases
EC 3.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102172Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210481
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M011194/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200646/Z/16/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.